Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study by Yung, W.K. Alfred, Vredenburgh, James J., Cloughesy, Timothy F., Nghiemphu, Phioanh, Klencke, Barbara, Gilbert, Mark R., Reardon, David A., Prados, Michael D.

Get full text

Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials by Van Heertum, Ronald L, Scarimbolo, Robert, Wolodzko, John G, Klencke, Barbara, Messmann, Richard, Tunc, Feza, Sokol, Levi, Agarwal, Rajan, Strafaci, James A, O'Neal, Michael

Get full text

Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: A Phase I study of ZYC101 by KLENCKE, Barbara, MATIJEVIC, Mark, JAY, Naomi, DA COSTA, Maria, PALEFSKY, Joel M, URBAN, Robert G, LATHEY, Janet L, HEDLEY, Mary Lynne, BERRY, Michael, THATCHER, Joe, WEINBERG, Vivian, WILSON, Jennifer, DARRAGH, Teresa

Get full text

5020 Pharmacokinetics (PK), safety, and efficacy of trastuzumab (T)-DM1, a HER2 antibody-drug conjugate (ADC), in patients with HER2+ metastatic breast cancer (MBC): phase I and ph... by Burris, H, Vukelja, S, Krop, I, Modi, S, Klencke, B, Girish, S, Sliwkowski, M.X, Dresser, M, Phillips, G.L, Rugo, H

Get full text

Improved Transfusion Independence Rates for Momelotinib versus Ruxolitinib in Anaemic Jaki Naive Myelofibrosis Patients Independent of Baseline Platelet or Transfusion Status by Kiladjian, JJ, Platzbecker, U, Mayer, J, Illes, A, Prejzner, W, Wozny, T, Vannucchi, AM, Kirgner, I, Nagy, Z, Grosicki, S, Derolf, A, Lazaroiu, MC, Yoon, SS, Goh, YT, Von Bubnoff, N, Verstovsek, S, Strouse, B, Klencke, B, Donahue, R, Mesa, R

Get full text

SABRE-B: a randomized phase II trial evaluating the safety and efficacy of combining sunitinib (S) with paclitaxel (P) + bevacizumab (B) as first-line treatment for HER2-negative m... by Mayer, E, Kozloff, M, Qamar, R, Klencke, B, Balkissoon, J, Parmar, H, Samant, M, Burstein, HJ

Get full text

A phase II study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer by Vukelja, S, Rugo, H, Vogel, C, Borson, R, Tan-Chiu, E, Birkner, M, Holden, SN, Klencke, B, O'Shaughnessy, J, Burris, HA

Get full text

P-492 A multicenter, open-label, phase Ilia trial of erlotinib in patients with advanced non-small cell lung cancer by Hainsworth, J., Spigel, D., O'Neill, V., Klencke, B.

Get full text

Improved Transfusion Independence Rates for Momelotinib vs Ruxolitinib in Anemic JAKi-Naive Myelofibrosis Patients are Independent of Baseline Platelet or Transfusion Status by Kiladjian, JJ, Platzbecker, U, Mayer, J, Illes, A, Prejzner, W, Wozny, T, Tzvetkov, N, Vannucchi, AM, Kirgner, I, Nagy, Z, Grosicki, S, Derolf, A, Lazaroiu, MC, Yoon, SS, Goh, YT, von Bubnoff, N, Mesa, R, Klencke, BJ, Donahue, R, Verstovsek, S

Get full text

CO96 Myelofibrosis Symptom Assessment Form Total Symptom Score (MFSAF TSS) v4.0: Measurement Properties from the Momentum Phase 3 Study by Daskalopoulou, C., Gorsh, B., Dumi, G., Deheshi, S., Gwaltney, C., von Maltzahn, R., Paty, J., Ellis, C., Kawashima, J., Klencke, B.J., Mesa, R.

Get full text

Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma by Westin, Jason, Maris, Michael B, Jacobson, Caron A, Patel, Prapti, Lakhani, Nehal, Harb, Wael, Patel-Donnelly, Dipti, McCaul, Kelly, Escobar, Carolina, Klencke, Barbara, Al-Katib, Ayad M.

Get full text